X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1148) 1148
index medicus (855) 855
antifungal agents - therapeutic use (728) 728
echinocandins (662) 662
male (561) 561
lipopeptides (552) 552
antifungal agents - administration & dosage (539) 539
caspofungin (502) 502
female (501) 501
pharmacology & pharmacy (480) 480
echinocandins - therapeutic use (447) 447
infectious diseases (431) 431
echinocandins - administration & dosage (417) 417
microbiology (417) 417
candidiasis - drug therapy (360) 360
micafungin (355) 355
antifungal agents - pharmacology (346) 346
middle aged (345) 345
adult (324) 324
antifungal agents (324) 324
voriconazole (312) 312
treatment outcome (304) 304
amphotericin-b (300) 300
fluconazole (297) 297
animals (291) 291
candidiasis (270) 270
aged (262) 262
drug therapy, combination (255) 255
echinocandin (240) 240
mycoses (235) 235
mycoses - drug therapy (233) 233
antifungal agents - adverse effects (226) 226
antifungal agents - pharmacokinetics (222) 222
echinocandins - pharmacology (221) 221
liposomal amphotericin-b (215) 215
aspergillosis - drug therapy (210) 210
pharmacokinetics (209) 209
microbial sensitivity tests (206) 206
invasive candidiasis (201) 201
aspergillosis (198) 198
health aspects (190) 190
anidulafungin (188) 188
amphotericin b (187) 187
fungal-infections (183) 183
amphotericin b - therapeutic use (181) 181
amphotericin b - administration & dosage (175) 175
drug therapy (168) 168
lipopeptides - administration & dosage (167) 167
candida (163) 163
adolescent (162) 162
echinocandins - pharmacokinetics (162) 162
echinocandins - adverse effects (160) 160
mycology (160) 160
triazoles - therapeutic use (160) 160
epidemiology (159) 159
therapy (159) 159
peptides, cyclic - therapeutic use (158) 158
candida - drug effects (154) 154
candidiasis - microbiology (153) 153
infections (153) 153
candidemia (151) 151
dosage and administration (151) 151
care and treatment (145) 145
invasive fungal-infections (143) 143
lipopeptides - therapeutic use (142) 142
transplantation (138) 138
immunology (136) 136
mice (131) 131
research (131) 131
mortality (130) 130
child (128) 128
bacterial infections and mycoses (127) 127
drug resistance, fungal (124) 124
immunocompromised host (121) 121
risk factors (121) 121
internal medicine (118) 118
efficacy (115) 115
medicine & public health (114) 114
fungal infections (113) 113
antifungal therapy (111) 111
peptides, cyclic - administration & dosage (111) 111
pyrimidines - therapeutic use (111) 111
retrospective studies (111) 111
safety (111) 111
in-vitro (110) 110
analysis (103) 103
triazoles - administration & dosage (102) 102
antifungal (101) 101
invasive aspergillosis (100) 100
antifungals (99) 99
dose-response relationship, drug (99) 99
blood-stream infections (95) 95
candida albicans - drug effects (95) 95
young adult (95) 95
aged, 80 and over (94) 94
double-blind (94) 94
pediatrics (94) 94
infection (93) 93
disease models, animal (92) 92
drug interactions (92) 92
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1425) 1425
Spanish (30) 30
Japanese (25) 25
French (21) 21
German (10) 10
Chinese (5) 5
Russian (3) 3
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Critical Care Medicine, ISSN 0090-3493, 03/2011, Volume 39, Issue 3, pp. 560 - 570
OBJECTIVE:To address issues of antibiotic dosing during sustained low-efficiency dialysis by using available pharmacokinetic data, intermittent and continuous... 
dialysis | continuous renal replacement therapy | critical care | pharmacokinetics | sustained low-efficiency dialysis | anti-infectives | antibiotics | ACUTE KIDNEY INJURY | SLEDD-F | INTERMITTENT HEMODIALYSIS | SEPTIC PATIENTS | UREA KINETICS | HIGH-FLUX HEMODIALYSIS | EXTENDED DAILY DIALYSIS | INTENSIVE-CARE-UNIT | DAILY DIAFILTRATION | RENAL REPLACEMENT THERAPY | CRITICAL CARE MEDICINE | Critical Care - methods | Linezolid | Carbapenems - administration & dosage | Echinocandins - pharmacokinetics | Humans | Renal Dialysis - methods | Carbapenems - pharmacokinetics | Oxazolidinones - administration & dosage | Fluoroquinolones - pharmacokinetics | Peritoneal Dialysis, Continuous Ambulatory - adverse effects | Echinocandins - administration & dosage | Aminoglycosides - administration & dosage | Fluoroquinolones - administration & dosage | Vancomycin - administration & dosage | Acetamides - pharmacokinetics | Aminoglycosides - pharmacokinetics | Oxazolidinones - pharmacokinetics | Peritoneal Dialysis, Continuous Ambulatory - methods | Renal Insufficiency - therapy | Vancomycin - pharmacokinetics | Anti-Bacterial Agents - pharmacokinetics | Renal Dialysis - adverse effects | Daptomycin - pharmacokinetics | Anti-Bacterial Agents - administration & dosage | Daptomycin - administration & dosage | Acetamides - administration & dosage
Journal Article
Journal Article
Journal Article
BMC Infectious Diseases, ISSN 1471-2334, 02/2014, Volume 14, Issue 1, pp. 97 - 97
Journal Article
Clinical Pharmacology & Therapeutics, ISSN 0009-9236, 02/2007, Volume 81, Issue 2, pp. 213 - 221
Exploratory analyses of data pertaining to pharmacokinetic, pharmacodynamic, and disease progression are often referred to as the pharmacometrics (PM)... 
PHARMACOLOGY & PHARMACY | EXPERIENCE | Drug Evaluation - methods | Lipoproteins - therapeutic use | Quinoxalines - adverse effects | Risk Assessment - methods | United States | Benzazepines - adverse effects | Humans | United States Food and Drug Administration - standards | Varenicline | Cyclosporins - administration & dosage | Data Collection | Peptides, Cyclic - administration & dosage | United States Food and Drug Administration - legislation & jurisprudence | Drug Labeling - legislation & jurisprudence | Cyclosporins - therapeutic use | Investigational New Drug Application - legislation & jurisprudence | Everolimus | Sirolimus - adverse effects | Lipoproteins - adverse effects | Quinoxalines - therapeutic use | Sirolimus - analogs & derivatives | Sirolimus - therapeutic use | Drug Administration Schedule | Peer Review | Quinoxalines - administration & dosage | Cyclosporins - adverse effects | Decision Support Techniques | Pharmacology, Clinical | Treatment Outcome | Disease Progression | Drug Approval - legislation & jurisprudence | Sirolimus - administration & dosage | Lipoproteins - administration & dosage | Benzazepines - therapeutic use | Echinocandins | Investigational New Drug Application - statistics & numerical data | Peptides, Cyclic - therapeutic use | Benzazepines - administration & dosage | Clinical Trials as Topic - methods | Pharmacokinetics | Lipopeptides | Peptides, Cyclic - adverse effects
Journal Article
Leukemia, ISSN 0887-6924, 03/2008, Volume 22, Issue 3, pp. 496 - 503
In patients with hematologic malignancy, invasive aspergillosis continues to be associated with high mortality even when treated with conventional antifungal... 
posaconazole | VORICONAZOLE | EFFICACY | SAFETY | caspofungin | FUNGAL-INFECTIONS | PATHOGENESIS | invasive aspergillosis | INTOLERANT | PULMONARY ASPERGILLOSIS | PHARMACOKINETICS | ONCOLOGY | LIPOSOMAL AMPHOTERICIN | SPECTRUM TRIAZOLE ANTIFUNGAL | HEMATOLOGY | hematologic malignancy | Phosphatidylglycerols - administration & dosage | Triazoles - administration & dosage | Humans | Middle Aged | Phosphatidylcholines - administration & dosage | Salvage Therapy | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Antifungal Agents - therapeutic use | Echinocandins - administration & dosage | Neutropenia - complications | Phosphatidylglycerols - therapeutic use | Aspergillosis - etiology | Fungemia - drug therapy | Voriconazole | Amphotericin B - administration & dosage | Adult | Female | Itraconazole - administration & dosage | Hematologic Neoplasms - complications | Drug Therapy, Combination | Neutropenia - chemically induced | Aspergillosis - drug therapy | Triazoles - therapeutic use | Pyrimidines - administration & dosage | Hematopoietic Stem Cell Transplantation | Treatment Outcome | Combined Modality Therapy | Hematologic Neoplasms - surgery | Itraconazole - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Pyrimidines - therapeutic use | Echinocandins - therapeutic use | Hematologic Neoplasms - drug therapy | Amphotericin B - therapeutic use | Antifungal Agents - administration & dosage | Lipopeptides | Drug Combinations | Phosphatidylcholines - therapeutic use
Journal Article
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 01/2012, Volume 56, Issue 1, pp. 584 - 587
Journal Article
Journal of Clinical Pharmacy and Therapeutics, ISSN 0269-4727, 06/2013, Volume 38, Issue 3, pp. 241 - 242
Journal Article
Journal Article